Thomas Strehl, CEO
Chief Executive Officer. Responsible for company strategy, financial funding, partners and business development. University degree in electrical engineering from TU Berlin, Germany. Track record of successfully managing companies, e.g. Lemke Diagnostic GmbH, and investments.
+49 511 940 804 53, thomas.strehl@senostic.com

Dr. Joachim Glaubitz, CSO
Chief Scientific Officer. Ph.D. in Biochemie from University of Tübingen, Germany. Executive Master of Business Administration from University of Zurich, Switzerland. Experience in the pharma industry, RT-PCR for HIV, SARS-CoV-2 at Roche in Switzerland and San Francisco, USA.
+49 511 940 804 52, joachim.glaubitz@senostic.com

Dr. Michèle Bachmann, Senior Scientist Assay Development
Contact: +49 511 940 804 73, michele.bachmann@senostic.com

Daniel Stumpf, PhD, Senior Scientist Assay Development
Contact: +49 511 940 804 66, daniel.stumpf@senostic.com

Lena Meyer, M.Sc., Scientist Assay Development
Contact: +49 511 940 804 69, lena.meyer@senostic.com

Ineke Koch, Scientist Protein Development
Contact: +49 511 940 804 63, ineke.koch@senostic.com

Imke Pollul, M.Sc., Scientist Protein Development
Contact: +49 511 940 804 83, imke.pollul@senostic.com

Julia Pott, Precision engineering
Contact: +49 511 940 804 67, julia.pott@senostic.com